A

Atara Biotherapeutics
D

ATRA

11.470
USD
0.81
(7.60%)
Market Closed
Volume
1,380
EPS
-17
Div Yield
-
P/E
-0
Market Cap
66,064,333
OverviewSignalsIdeasNews
Related Instruments
    A
    ARRY
    -0.79000
    (-10.35%)
    6.84500 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    L
    LGND
    -3.790
    (-3.28%)
    111.690 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    More
News

Title: Atara Biotherapeutics Inc.

Sector: Healthcare
Industry: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).